Skip to Content Facebook Feature Image

Traditional Chinese medicine gains global traction at Canton Fair

China

China

China

Traditional Chinese medicine gains global traction at Canton Fair

2024-11-02 18:42 Last Updated At:19:27

The booths dedicated to Traditional Chinese Medicine (TCM) at the China Import and Export Fair, or Canton Fair, are bustling with activity, attracting a diverse array of global purchasers, from seasoned partners to newcomers.

The third phase of the 136th session of the Canton Fair opened in Guangzhou of south China's Guangdong Province on Thursday, presenting products in recreation and health sectors, with TCM receiving many buyers' attention.

"Your medicines and your hospitality is very nice. So we need to try your medicine in our country," said Indian purchaser Hisham Thari.

"In our country, the pharmaceutical industry, our main ingredients, we use more active ingredients than China. It's not so much based on the nature like China does," said Mexican importer Uriel Arsenio Angulo Castro.

"Chinese medicine is more than competitive. It is very interesting. That's why I come here. I don't go to Europe or U.S. or somewhere else, I come here, because what I want is natural medicine," said Raymond Tchappet, a buyer from Cameroon.

During the first three quarters of 2024, China's pharmaceutical product imports and exports totaled 147 billion U.S. dollars. The export value reached 79 billion U.S. dollars, which was more than 3.1-percent higher than the previous year. The six-decade old Canton Fair has served as a crucial bridge for domestic companies to access the global market.

To fit in with international markets, China's medical industry has set standards that adhere to global norms and practices.

"Traditional Chinese Medicine is unique, so to sell it internationally, the production system and products must be approved by the relevant authorities in other countries. Our products have already passed the tests and been registered in over 32 countries and regions. So, we can sell them there," said Huang Wei, vice president of Lanzhou Foci International Commerce. "We have completed the registration process and met the local requirements and standards. That's why we are able to sell our products in Southeast Asia, including Singapore, Indonesia, and Malaysia, as well as in the United States, Russia, and Ukraine," said Zhao Deng, manager of Mayinglong Pharmaceutical Group.

TCM has been spanning 196 countries and regions. Remarkably, over one-third of the world's population has received treatment through traditional Chinese medicine. With policy and cultural exchanges intensifying, the global influence of TCM is expected to surge even further.

Traditional Chinese medicine gains global traction at Canton Fair

Traditional Chinese medicine gains global traction at Canton Fair

U.S. stocks finished slightly higher on Monday, staging a late-session recovery as investors navigated a volatile landscape marked by a criminal probe into the Federal Reserve leadership.

The Dow Jones Industrial Average rose 86.13 points, or 0.17 percent, to 49,590.2. The S&P 500 added 10.99 points, or 0.16 percent, to 6,977.27. The Nasdaq Composite Index increased by 62.56 points, or 0.26 percent, to 23,733.9. Despite the positive close, the market experienced significant intraday turbulence, with the Dow dropping nearly 500 points at its session lows.

Nine of the 11 primary S&P 500 sectors ended in positive territory. Consumer staples and industrials led the gainers, rising 1.42 percent and 0.75 percent, respectively. Financials and energy were the primary laggards, declining 0.8 percent and 0.66 percent.

Market sentiment was initially shaken by an announcement on Sunday from Fed Chair Jerome Powell, who confirmed that federal prosecutors are investigating him over the Fed's multi-billion-dollar project to renovate its headquarters. Powell characterized the probe as an attempt by the Trump administration to compromise the Fed's independence.

Further weighing on the financial sector was a proposal by U.S. President Donald Trump to cap credit card interest rates at 10 percent for one year, which triggered a sell-off in banking stocks amid concerns over restricted lending and reduced profitability. Capital One shares plummeted 6.42 percent, while Citigroup, JPMorgan and Bank of America also recorded losses.

In contrast, retail giant Walmart led the Dow's advance, climbing 3 percent following news of its upcoming inclusion in the Nasdaq 100 index. The company also announced a strategic partnership with Google's Gemini AI to enhance the digital shopping experience.

Investors are awaiting Tuesday's release of the U.S. consumer price index for December 2025. Following last week's cooling labor market data, market participants increasingly expect the Fed to maintain interest rates at their current levels during the upcoming January meeting.

U.S. stocks close higher amid criminal probe into Fed chair Powell

U.S. stocks close higher amid criminal probe into Fed chair Powell

Recommended Articles